Annovis Bio Correlations
| ANVS Stock | USD 6.65 0.14 2.06% |
The current 90-days correlation between Annovis Bio and Scpharmaceuticals is 0.29 (i.e., Modest diversification). The correlation of Annovis Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Annovis Bio Correlation With Market
Average diversification
The correlation between Annovis Bio and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Annovis Bio and DJI in the same portfolio, assuming nothing else is changed.
Annovis |
Moving together with Annovis Stock
Moving against Annovis Stock
| 0.66 | RNXT | RenovoRx | PairCorr |
| 0.43 | MDGL | Madrigal Pharmaceuticals | PairCorr |
| 0.44 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.43 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.4 | T | ATT Inc Aggressive Push | PairCorr |
| 0.38 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.36 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
Related Correlations Analysis
| -0.01 | 0.87 | -0.52 | 0.83 | -0.66 | ELYM | ||
| -0.01 | -0.17 | 0.1 | 0.11 | 0.01 | HCWB | ||
| 0.87 | -0.17 | -0.52 | 0.72 | -0.57 | SCPH | ||
| -0.52 | 0.1 | -0.52 | -0.42 | 0.49 | MIST | ||
| 0.83 | 0.11 | 0.72 | -0.42 | -0.6 | MCRB | ||
| -0.66 | 0.01 | -0.57 | 0.49 | -0.6 | LUMO | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Annovis Stock performing well and Annovis Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Annovis Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ELYM | 3.92 | (0.95) | 0.00 | (5.36) | 0.00 | 6.21 | 34.87 | |||
| HCWB | 13.22 | 4.45 | 0.42 | (1.48) | 7.39 | 22.00 | 352.85 | |||
| SCPH | 2.68 | (0.82) | 0.00 | (0.32) | 0.00 | 4.30 | 20.70 | |||
| MIST | 1.92 | 0.21 | 0.13 | 0.25 | 1.60 | 7.19 | 18.66 | |||
| MCRB | 4.68 | 0.01 | (0.02) | 0.25 | 5.68 | 10.00 | 28.84 | |||
| LUMO | 2.77 | 0.61 | 0.15 | (3.14) | 2.60 | 6.35 | 26.13 |
Annovis Bio Corporate Management
| Hilda Maibach | Senior Statistics | Profile | |
| Michael Hoffman | Independent Director Chairman of the Board | Profile | |
| RAC MS | Senior Operations | Profile | |
| Claudine Bruck | Independent Director | Profile | |
| MBA III | Chief Officer | Profile |